Summit Therapeutics Inc. (SMMT)

NASDAQ: SMMT · Real-Time Price · USD

26.87

+1.18 (4.59%)

At close: Aug 13, 2025, 4:00 PM

26.96

+0.09 (0.33%)

Pre-market: Aug 14, 2025, 4:45 AM EDT

Summit Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Aug '25 Aug 13, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	19,960	13,160	1,829	897	263	387	Upgrade
Market Cap Growth	188.63%	619.43%	103.94%	241.23%	-32.01%	-28.06%	Upgrade
Enterprise Value	19,668	12,705	1,737	779	184	366	Upgrade
Last Close Price	26.87	17.84	2.61	4.25	2.69	4.70	Upgrade
PS Ratio	-	-	-	1272.24	145.30	449.56	Upgrade
PB Ratio	76.93	33.85	23.54	7.08	3.16	4.87	Upgrade
P/TBV Ratio	77.55	34.02	24.13	7.18	3.71	5.87	Upgrade
EV/Sales Ratio	-	-	-	1105.42	101.96	425.47	Upgrade
Debt / Equity Ratio	0.02	0.02	1.37	4.10	0.03	0.01	Upgrade
Asset Turnover	-	-	-	0.00	0.02	0.01	Upgrade
Quick Ratio	4.94	9.90	9.17	9.15	3.47	3.85	Upgrade
Current Ratio	5.13	10.15	9.30	16.93	3.80	4.41	Upgrade
Return on Equity (ROE)	-328.30%	-94.89%	-601.85%	-75.05%	-108.89%	-66.57%	Upgrade
Return on Assets (ROA)	-142.53%	-41.30%	-12.79%	-10.23%	-49.91%	-32.91%	Upgrade
Return on Capital (ROIC)	-166.87%	-45.49%	-13.38%	-10.87%	-64.91%	-40.97%	Upgrade
Earnings Yield	-3.74%	-1.68%	-33.62%	-8.78%	-33.71%	-13.63%	Upgrade
FCF Yield	-1.04%	-1.08%	-4.20%	-4.71%	-27.73%	-12.55%	Upgrade
Buyback Yield / Dilution	-4.79%	-15.96%	-220.50%	-109.60%	-32.67%	-111.78%	Upgrade

Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q